Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

GP nurses could deliver effective sleep treatments

22

Apr 2026

GP nurses could deliver effective sleep treatments

A new Flinders University study shows that nurses working in general practice could play a major role in improving access to sleep‑health treatment, but only if patients and general practice staff are involved in designing these services.

Yoga may improve cardiometabolic health in overweight adults

22

Apr 2026

Yoga may improve cardiometabolic health in overweight adults

Practicing yoga could help people with overweight or obesity improve their cardiometabolic health, according to a study published April 22 in the open-access journal PLOS Global Public Health by Widya Wasityastuti from the University of Edinburgh, Scotland, and colleagues.

Poor sleep linked to higher dementia risk in epilepsy

22

Apr 2026

Poor sleep linked to higher dementia risk in epilepsy

For people with epilepsy, getting poor sleep was associated with a higher risk of dementia compared to people without epilepsy, according to a study published April 22, 2026, in Neurology, the medical journal of the American Academy of Neurology.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.